Clinical trial
A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
NCT00348790 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
- Lead sponsor
- Northwestern University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- July 31, 2013
- Enrollment
- 25 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
brain and central nervous system tumors, sarcoma